# BLOCKCHAIN BIOPHARMA: INVESTMENT GOALS AND CRITERIA DATA

![Currently, we are working to integrate 26 different global derivative and cryptocurrency trading platforms to list our Pharmaceutical Token (Ticker: PHARMA)](https://3793447250-files.gitbook.io/~/files/v0/b/gitbook-x-prod.appspot.com/o/spaces%2FO7W4pc5eosLdhomkAh7o%2Fuploads%2F4zGKKZs5uthE8YO3FJDu%2Fstock-market-data-investment-2021-08-29-08-15-11-utc.jpg?alt=media\&token=f4185eff-888f-4ad7-b7a1-fd6ad960c0f9)

We have selected #Consensys's MetaMask Institutional Account, and several other high-security / high-quality Crypto Wallets to safely store Pharmaceutical Tokens (Ticker: PHARMA), including cold-storage. 

* TIME-FRAME
  * 3-Months<br>
* MINIMUM NEEDED FOR COMMERCIAL VIABILITY
  * $25 Million<br>
* MAXIMUM NEEDED FOR CROWD FUNDING SERIES A, B, C
  * $300 Million<br>
* $25 MM Seed Round
  * Investors will be granted voting rights in the DAO, powered by transparent Voting Smart Contracts. Collaboration in this early stage is critical, and we seek partners with a vested interest in the success of Blockchain BioPharma's #Mission. We want only high performers.<br>
* MINIMUM TOKEN PRICING FOR ENTERPRISES:
  * $6.00 - 1 Million PHARMA Tokens Purchased
  * $5.00 - 2 Million PHARMA Tokens Purchased
  * $4.00 - 3 Million PHARMA Tokens Purchased<br>
* CASH FLOW REQUIREMENTS WITH $20(M) INVESTMENT MINIMUM
  * \[$500(k)] = Monthly Startup Burn Data (Platform Development, Advertising / Partnership Development, Survey, Research & Development, and Scrum Team)
  * \[$250(k)] = Remaining Regulatory Licensing Costs
  * \[$100,000(k)] = Approximate 3rd - Party Data Providers
  * \[$50(k) = Auditing and Remittal of Audits via [#Regulatory](https://www.linkedin.com/feed/hashtag/?keywords=regulatory\&highlightedUpdateUrns=urn%3Ali%3Aactivity%3A6907102456535470080) and [#Compliance](https://www.linkedin.com/feed/hashtag/?keywords=compliance\&highlightedUpdateUrns=urn%3Ali%3Aactivity%3A6907102456535470080) Smart Contracts $100,000

Software Products & Services

WE DO NOT MAKE INVESTMENT RETURN PROMISES THUS NO PRO-FORMAS. WE ONLY PRESENT EXISTING QUALITATIVE AND QUANTITAVE DATA AVAILABLE

*CRYPTO IS A RISKY BUSINESS* – LASTLY, VOTERS IN OUR DECENTRALIZED AUTONOMOUS ORGANIZATION WILL INFORM THE BUSINESS, eNFT INVESTMENT, AND MANAGEMENT DECISIONS - TARGET DATE Q2 2022.&#x20;

**REQUIRED READING:**

The US Treasure Departments Stablecoin Analysis

o   Investor Relations Contact: <Developers@BlockchainBiopharma.com>